Wilmington Savings Fund Society’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Wilmington Savings Fund Society’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25	Closed	–	–	354
2018 Q4	$0	Hold	25	–	–	﹤0.01%	361
2018 Q3	$2K	Hold	25	–	–	﹤0.01%	361
2018 Q2	$2K	Hold	25	–	–	﹤0.01%	364
2018 Q1	$2K	Hold	25	–	–	﹤0.01%	345
2017 Q4	$19K	Hold	25	–	–	﹤0.01%	343
2017 Q3	$7K	Hold	25	–	–	﹤0.01%	337
2017 Q2	$6K	Hold	25	–	–	﹤0.01%	342
2017 Q1	$8K	Hold	25	–	–	﹤0.01%	337
2016 Q4	$15K	Hold	25	–	–	﹤0.01%	327
2016 Q3	$28K	Hold	25	–	–	﹤0.01%	329
2016 Q2	$27K	Hold	25	–	–	﹤0.01%	333
2016 Q1	$32K	Hold	25	–	–	﹤0.01%	344
2015 Q4	$61K	Hold	25	–	–	﹤0.01%	348
2015 Q3	$28K	Hold	25	–	–	﹤0.01%	348
2015 Q2	$25K	Buy	+25	New	+$27K	﹤0.01%	357

Other funds holding NBSE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIG

Mariner Investment Group Harrison, New York $463M AUM 13.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSB

Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return

WAM

Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return

Wilmington Savings Fund Society's NBSE Position: Q1 2019 in Review

Wilmington Savings Fund Society sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2019, closing a stake of 25 shares.

Wilmington Savings Fund Society first reported a position in NBSE in Q2 2015 and held it in 15 quarters. The position peaked at $61K in Q4 2015. 15 funds tracked by Wall St. Rank hold NBSE as of Q1 2019.

Wilmington Savings Fund Society reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Wilmington Savings Fund Society sold 25 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2019.
Wilmington Savings Fund Society first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2015 and held it in 15 quarters.
Wilmington Savings Fund Society's NeuBase Therapeutics, Inc. Common Stock position peaked at $61K in Q4 2015.
15 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2019, filed 15 May 2019.